› Forums › General Melanoma Community › Possible cure?
- This topic has 15 replies, 5 voices, and was last updated 9 years ago by Squash.
- Post
-
- April 8, 2015 at 10:07 pm
I'm new here – but how much do you guys know about this already?
http://m.ksl.com/index/story/sid/34059559?mobile_direct=y
- Replies
-
-
- April 9, 2015 at 12:01 am
It's part of the virus based treatments going on. Other places are trying other types of viruses. Virus treatments are getting a lot of news probably because they are rather new and can have dramatic results. As far as a cure the data and time will tell. Apparently they have had a 60% response rate so far if I read into what they are saying with the anticipation of making it even better. So in my opinion that is already fantastic. Keytruda pd1 in the best trial arm I read had about 42% and the fda approved dose was 25% granted there are probably other data about it I haven't seen with different numbers.
So in my opinion getting that response rate with a fairly mild virus compared with some of the others like polio is fantastic. However it seems the patient must have surface lesions thus leaving out some patients. Plus those who have been on immunotherapy I wonder if this type of treatment could even work because we already have a boosted immune system so can this treatment even have a chance to work seems unknown. So really lots of unknowns but very exciting stuff.
Artie
-
- April 9, 2015 at 12:54 am
I'm new here as well (on behalf of my husband who is about to have surgery this Friday). Stories like this are very exciting and I've learned so much in the past few weeks about this cancer and the AMAZING trials that are offered across the country. Thank you for sharing.
-
- April 9, 2015 at 12:54 am
I'm new here as well (on behalf of my husband who is about to have surgery this Friday). Stories like this are very exciting and I've learned so much in the past few weeks about this cancer and the AMAZING trials that are offered across the country. Thank you for sharing.
-
- April 9, 2015 at 12:54 am
I'm new here as well (on behalf of my husband who is about to have surgery this Friday). Stories like this are very exciting and I've learned so much in the past few weeks about this cancer and the AMAZING trials that are offered across the country. Thank you for sharing.
-
- April 9, 2015 at 12:01 am
It's part of the virus based treatments going on. Other places are trying other types of viruses. Virus treatments are getting a lot of news probably because they are rather new and can have dramatic results. As far as a cure the data and time will tell. Apparently they have had a 60% response rate so far if I read into what they are saying with the anticipation of making it even better. So in my opinion that is already fantastic. Keytruda pd1 in the best trial arm I read had about 42% and the fda approved dose was 25% granted there are probably other data about it I haven't seen with different numbers.
So in my opinion getting that response rate with a fairly mild virus compared with some of the others like polio is fantastic. However it seems the patient must have surface lesions thus leaving out some patients. Plus those who have been on immunotherapy I wonder if this type of treatment could even work because we already have a boosted immune system so can this treatment even have a chance to work seems unknown. So really lots of unknowns but very exciting stuff.
Artie
-
- April 9, 2015 at 12:01 am
It's part of the virus based treatments going on. Other places are trying other types of viruses. Virus treatments are getting a lot of news probably because they are rather new and can have dramatic results. As far as a cure the data and time will tell. Apparently they have had a 60% response rate so far if I read into what they are saying with the anticipation of making it even better. So in my opinion that is already fantastic. Keytruda pd1 in the best trial arm I read had about 42% and the fda approved dose was 25% granted there are probably other data about it I haven't seen with different numbers.
So in my opinion getting that response rate with a fairly mild virus compared with some of the others like polio is fantastic. However it seems the patient must have surface lesions thus leaving out some patients. Plus those who have been on immunotherapy I wonder if this type of treatment could even work because we already have a boosted immune system so can this treatment even have a chance to work seems unknown. So really lots of unknowns but very exciting stuff.
Artie
-
- April 9, 2015 at 1:58 pm
Wow, 60% is huge! I did some googling and found a link to the trial at the Huntsman site: http://healthcare.utah.edu/huntsmancancerinstitute/clinical-trials/find-clinical-trials-at-hci/melanoma.php. According to it the trial combines ipi with a HSV-1 oncolytic virus. It does not appear the tumor must be presenting on the skin, just that it cannot be visceral. Looking at the elegibility criteria, it does say the patient must never have been on ipi.
I found the trial at the clinicaltrials.gov site (https://www.clinicaltrials.gov/ct2/show/NCT02272855) and it looks like there are multiple locations for the trial but that enrollment is limited to 43 patients (it is a phase 2 trial).
-
- April 9, 2015 at 1:58 pm
Wow, 60% is huge! I did some googling and found a link to the trial at the Huntsman site: http://healthcare.utah.edu/huntsmancancerinstitute/clinical-trials/find-clinical-trials-at-hci/melanoma.php. According to it the trial combines ipi with a HSV-1 oncolytic virus. It does not appear the tumor must be presenting on the skin, just that it cannot be visceral. Looking at the elegibility criteria, it does say the patient must never have been on ipi.
I found the trial at the clinicaltrials.gov site (https://www.clinicaltrials.gov/ct2/show/NCT02272855) and it looks like there are multiple locations for the trial but that enrollment is limited to 43 patients (it is a phase 2 trial).
-
- April 9, 2015 at 1:58 pm
Wow, 60% is huge! I did some googling and found a link to the trial at the Huntsman site: http://healthcare.utah.edu/huntsmancancerinstitute/clinical-trials/find-clinical-trials-at-hci/melanoma.php. According to it the trial combines ipi with a HSV-1 oncolytic virus. It does not appear the tumor must be presenting on the skin, just that it cannot be visceral. Looking at the elegibility criteria, it does say the patient must never have been on ipi.
I found the trial at the clinicaltrials.gov site (https://www.clinicaltrials.gov/ct2/show/NCT02272855) and it looks like there are multiple locations for the trial but that enrollment is limited to 43 patients (it is a phase 2 trial).
-
- April 10, 2015 at 2:34 am
Rigvir is used in Europe to treat melanoma with some success. It is a virus also and has been around for years. It is not biologically engineered so it is very safe to use.
Not sure why it isnt used in US but vaccines seem the way forward far better than any of the toxic drugs that are currently being used to treat melanoma.
-
- April 10, 2015 at 2:34 am
Rigvir is used in Europe to treat melanoma with some success. It is a virus also and has been around for years. It is not biologically engineered so it is very safe to use.
Not sure why it isnt used in US but vaccines seem the way forward far better than any of the toxic drugs that are currently being used to treat melanoma.
-
- April 10, 2015 at 2:34 am
Rigvir is used in Europe to treat melanoma with some success. It is a virus also and has been around for years. It is not biologically engineered so it is very safe to use.
Not sure why it isnt used in US but vaccines seem the way forward far better than any of the toxic drugs that are currently being used to treat melanoma.
- You must be logged in to reply to this topic.